Clinical trials show progress in migraine frequency, skin cancer prevention

-
2:27
Wisconsin mom celebrates Mother’s Day after receiving rare...
-
4:38
Schlesinger’s Saturday Spotlight (5/10)...Plenty of mom fun...
-
3:14
You know the deal, mom. Cooler by the lake!
-
2:17
Milwaukee Archbishop Grob reflects on election of Pope Leo XIV
-
1:16
Siblings honored with Red Cross award for helping to save father’s...
-
2:18
Excitement grows over new pope’s Midwest and Peruvian ties
-
1:49
’There’s nothing better’: Big Boat Day at Milwaukee Community...
-
2:54
Records show Madison school shooter flagged for ’high-risk’...
-
0:55
Milwaukee Fire Chief Aaron Lipski reads to kids at Next Door...
-
2:10
Milwaukee Diaper Mission, CBS 58 team up for 2025 Mother’s...
-
1:27
An ’udderly’ fun game: Milwaukee Milkmen return to the field...
-
2:05
Sirens, gunshots and explosions heard in Fredonia; suspect taken...
MILWAUKEE (CBS 58) -- Clinical research studies are aiming to shed new light on the treatment of migraines and skin cancer. One investigates the potential use of a heart device to reduce migraines, while the other seeks to determine the optimal excision size in melanoma treatment.
Dr. Nina Garlie, Vice President of Clinical Trials Research at Aurora Health Care joined us on Thursday, May 25 to discuss these studies.
As part of the National Migraine and Headache Awareness Month in June, Dr. Garlie discussed the link between a particular heart condition and the frequency of migraines.
Also, with the advent of summer and the increased need for skin protection, she also elaborated on a clinical trial addressing skin cancer treatment specifics.
To learn more about the clinical trials and medical research conducted by Aurora Health Care, visit AAH.org/Research.